Cargando…
MSC surface markers (CD44, CD73, and CD90) can identify human MSC-derived extracellular vesicles by conventional flow cytometry
BACKGROUND: Human mesenchymal stromal cells (hMSC) are multipotent cells with both regenerative and immunomodulatory activities making them an attractive tool for cellular therapy. In the last few years it has been shown that the beneficial effects of hMSC may be due to paracrine effects and, at lea...
Autores principales: | L. Ramos, Teresa, Sánchez-Abarca, Luis Ignacio, Muntión, Sandra, Preciado, Silvia, Puig, Noemí, López-Ruano, Guillermo, Hernández-Hernández, Ángel, Redondo, Alba, Ortega, Rebeca, Rodríguez, Concepción, Sánchez-Guijo, Fermín, del Cañizo, Consuelo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4709865/ https://www.ncbi.nlm.nih.gov/pubmed/26754424 http://dx.doi.org/10.1186/s12964-015-0124-8 |
Ejemplares similares
-
Mesenchymal stromal cells (MSC) from JAK2(+) myeloproliferative neoplasms differ from normal MSC and contribute to the maintenance of neoplastic hematopoiesis
por: Ramos, Teresa L., et al.
Publicado: (2017) -
Co-administration of human MSC overexpressing HIF-1α increases human CD34(+) cell engraftment in vivo
por: Preciado, Silvia, et al.
Publicado: (2021) -
HDAC8 overexpression in mesenchymal stromal cells from JAK2(+) myeloproliferative neoplasms: a new therapeutic target?
por: Ramos, Teresa L., et al.
Publicado: (2017) -
The Incorporation of Extracellular Vesicles from Mesenchymal Stromal Cells Into CD34(+) Cells Increases Their Clonogenic Capacity and Bone Marrow Lodging Ability
por: Preciado, Silvia, et al.
Publicado: (2019) -
Optimization of Mesenchymal Stromal Cell (MSC) Manufacturing Processes for a Better Therapeutic Outcome
por: Fernández-Santos, Maria Eugenia, et al.
Publicado: (2022)